Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by O.S.h. Chan
P2.01-53 Local Treatment for Oligoprogression/Oligometastases After Failure to Crizotinib for ALK-Rearranged Stage IV Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
OA07.02 ATOM: A Phase II Study to Assess Efficacy of Preemptive Local Ablative Therapy to Residual Oligometastases After EGFR TKI
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
P121 Clinical Value of Local Therapy in Advanced Crizotinib-Treated ALK-Rearranged Lung Cancer: Pattern of Failure Analyses
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Complete Pathological Response to Crizotinib in a Patient With ALK-rearranged Lung Adenocarcinoma
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
P2.01-89 Synergistic Cytotoxicity Through MAPK/ERK Pathway and ALK Inhibition in Crizotinib Resistant EML4-ALK-Positive Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Serial Liquid Biopsies for Detection of Treatment Failure and Profiling of Resistance Mechanisms in KLC1-ALK Rearranged Lung Cancer
Cold Spring Harbor molecular case studies
Biochemistry
Molecular Medicine
Genetics
P1.01-05 Metformin in Combination With Crizotinib for the Treatment of EML4-ALK+ Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.13-03 Ensartinib Treatment Beyond Disease Progression in Stage IV ALK+ Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P071 Variants Distribution and Heterogeneity of Outcomes to Crizotinib in ALK-Rearranged Chinese Non-Small Cell Lung Cancers
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
ASCEND-2: A Canary in a Coal Mine for Descending to Second-Line Treatment for ALK-rearranged Non-Small Cell Lung Cancer
Translational Lung Cancer Research
Oncology
Molecular Mechanisms of Resistance to First- And Second-Generation ALK Inhibitors in ALK-rearranged Lung Cancer
European Journal of Cancer
Cancer Research
Oncology